Zacks Investment Research Lowers Gevo (NASDAQ:GEVO) to Sell

Zacks Investment Research lowered shares of Gevo (NASDAQ:GEVO) from a hold rating to a sell rating in a research report sent to investors on Wednesday, reports.

According to Zacks, “Gevo, Inc. is a renewable chemicals and advanced biofuels company engaged in the development of biobased alternatives to petroleum-based products using a combination of synthetic biology and chemistry. The Company is focused on the commercialization of isobutanol, a naturally occurring four carbon alcohol with broad applications in large chemicals and fuels markets. Isobutanol can be used as a solvent and a gasoline blendstock and can be further processed into jet fuel and feedstocks for the production of synthetic rubber, plastics and polyesters. Markets served by the Company include solvents and coatings, materials, plastics and fibers, biojet blendstock, gasoline blendstock and other hydrocarbon fuels. “

GEVO has been the topic of several other research reports. ValuEngine downgraded Gevo from a buy rating to a hold rating in a research note on Friday, August 16th. HC Wainwright reaffirmed a buy rating and set a $10.00 target price on shares of Gevo in a research note on Thursday, August 15th.

Shares of Gevo stock opened at $2.74 on Wednesday. The business’s fifty day moving average price is $2.46 and its two-hundred day moving average price is $2.26. The company has a market capitalization of $37.32 million, a P/E ratio of -0.52 and a beta of 2.70. Gevo has a 1-year low of $1.79 and a 1-year high of $4.97.

In other Gevo news, insider Timothy J. Cesarek bought 25,000 shares of the business’s stock in a transaction on Thursday, June 6th. The shares were purchased at an average price of $1.91 per share, with a total value of $47,750.00. Following the purchase, the insider now directly owns 30,000 shares of the company’s stock, valued at $57,300. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 3.41% of the stock is owned by insiders.

A hedge fund recently bought a new stake in Gevo stock. Wedbush Securities Inc. bought a new stake in shares of Gevo Inc (NASDAQ:GEVO) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund bought 30,500 shares of the energy company’s stock, valued at approximately $67,000. Wedbush Securities Inc. owned approximately 0.26% of Gevo at the end of the most recent reporting period. 6.91% of the stock is currently owned by institutional investors.

About Gevo

Gevo, Inc is a renewable chemicals and next generation biofuels company, which focuses on the development and commercialization of renewable alternatives to petroleum-based products. It operates through the following segments: Gevo; Gevo Development and Agri-Energy. The Gevo segment focuses in the research and development activities related to the future production of isobutanol, including the development of the firm’s proprietary biocatalysts, the production and sale of renewable jet and other fuels, the retrofit process, and the next generation of chemicals and biofuels that will be based on the company’s isobutanol technology.

Featured Article: What is the Coverage Ratio?

Get a free copy of the Zacks research report on Gevo (GEVO)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Gevo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo and related companies with's FREE daily email newsletter.